Naloxone-does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose

Addiction

Volumn 110, Issue 10, 2015, Pages 1644-1652

  Neale, Joanne ^a   Strang, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Contemporary legend; Naloxone; Opiates; Overdose; Qualitative study

Indexed keywords

DIAMORPHINE; NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADOLESCENT; ADULT; DRUG OVERDOSE; EMERGENCY TREATMENT; FEMALE; HOSPITAL EMERGENCY SERVICE; HUMAN; IATROGENIC DISEASE; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITATIVE RESEARCH; SCOTLAND; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT REFUSAL; YOUNG ADULT;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; DRUG OVERDOSE; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; FEMALE; HEROIN; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; PATIENT SATISFACTION; QUALITATIVE RESEARCH; SCOTLAND; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT REFUSAL; YOUNG ADULT;

EID: 84941118946     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13027     Document Type: Article

References (50)

1. Sporer K. A., Firestone J., Isaacs S. M. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med 1996; 3: 660-7.
2. Sporer K. A. Acute heroin overdose. Ann Intern Med 1999; 130: 584-90.
3. Clarke S. F., Dargan P. I., Jones A. L. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 2005; 22: 612-6.
4. Bennett T., Holloway K. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN Project in Wales. Drugs Educ Prev Policy 2012; 19: 320-8.
5. Strang J., Darke S., Hall W., Farrell M., Ali R. Heroin overdose: the case for take-home naloxone. BMJ 1996; 312: 1435-6.
6. Dettmer K., Saunders B., Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ 2001; 322: 895-6.
7. Sporer K. A. Strategies for preventing heroin overdose. BMJ 2003; 326: 442-4.
8. Maxwell S., Bigg D., Stanczykiewicz K., Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006; 25: 89-96.
9. Sporer K. A., Kral A. H. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007; 49: 172-7.
10. Strang J., Manning V., Mayet S., Best D., Titherington E., Santana L. et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008; 103: 1648-57.
11. Green T. C., Heimer R., Grau L. E. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 2008; 103: 979-89.
12. Walley A. Y., Xuan Z., Hackman H. H., Quinn E., Doe-Simkins M., Sorensen-Alawad A. et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013; 346: f174.
13. Coffin P. O., Sullivan S. D. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med 2013; 158: 1-9.
14. Doe-Simkins M., Quinn E., Xuan Z., Sorensen-Alawad A., Hackman H., Ozonoff A. et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health 2014; 14: 297.
15. Davis C. S., Ruiz S., Glynn P., Picariello G., Walley A. Y. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health 2014; 104: e7-9.
16. Strang J., Bird S. M., Dietze P., Gerra G., McLellan A. T. Take-home emergency naloxone to prevent deaths from heroin overdose. BMJ 2014; 349: g6580.
17. McAuley A., Best D., Taylor A., Hunter C., Robertson R. From evidence to policy: the Scottish national naloxone programme. Drugs Educ Prev Policy 2012; 19: 309-19.
18. https://www.youtube.com/watch?v=OR2XoQExPCw&feature=youtu.be 18 Dec 2014. Take-home naloxone programmes in Europe-overdose prevention.
19. Clark A. K., Wilder C. M., Winstanley E. L. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med 2014; 8: 153-63.
20. Gaddis G. M., Watson W. A. Naloxone-associated patient violence: an overlooked toxicity? Ann Pharmacother 1992; 26: 196-8.
21. Wanger K., Brough L., Macmillan I., Goulding J., MacPhail I., Christenson J. M. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med 1998; 5: 293-9.
22. Rudolph S. S., Jehu G., Nielsen S. L., Nielsen K., Siersma V., Rasmussen L. S. Prehospital treatment of opioid overdose in Copenhagen-is it safe to discharge on-scene? Resuscitation 2011; 82: 1414-8.
23. Smith D. A., Leake L., Loflin J. R., Yealy D. M. Is admission after intravenous heroin overdose necessary? Ann Emerg Med 1992; 21: 1326-30.
24. Christenson J., Etherington J., Grafstein E., Innes G., Pennington S., Wanger K. et al. Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule. Acad Emerg Med 2000; 7: 1110-8.
25. Clarke S., Dargan P. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Intravenous bolus or infusion of naloxone in opioid overdose. Emerg. Med. J. 2002; 19: 249-50.
26. Boyd J. J., Kuisma M. J., Alaspaa A. O., Vuori E., Repo J. V., Randell T. T. Recurrent opioid toxicity after pre-hospital care of presumed heroin overdose patients. Acta Anaesthesiol Scand 2006; 50: 1266-70.
27. Wampler D. A., Molina D. K., McManus J., Laws F., Manifold C. A. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care 2011; 15: 320-4.
28. Vilke G. M., Buchanan J., Dunford J. V., Chan T. C. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care 1999; 3: 183-6.
29. Vilke G. M., Sloane C., Smith A. M., Chan T. C. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport. Acad Emerg Med 2003; 10: 893-6.
30. Buajordet I., Naess A. C., Jacobsen D., Brørs O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med 2004; 11: 19-23.
31. http://www.unodc.org/docs/treatment/overdose.pdf 2013, Opioid overdose: preventing and reducing opioid overdose mortality.
32. http://apps.who.int/iris/bitstream/10665/137462/1/9789241548816_eng.pdf?ua=1 2014, Guidelines on community emergency management of opioid overdose.
33. Neale J. Experiences of illicit drug overdose: an ethnographic study of emergency hospital attendances. Contemp Drug Probl 1999; 26: 505-30.
34. Neale J. Drug Users in Society. London: Palgrave Macmillan; 2002.
35. Ritchie J., Spencer L. Qualitative data analysis for applied policy research. In: Bryman A., Burgess R. G. editors. Analyzing Qualitative Data. London: Routledge; 1994, pp. 192-4.
36. Neale J., Miller P., West R. Reporting quantitative information in qualitative research: guidance for authors and reviewers. Addiction 2014; 109: 175-6.
37. Bonito A. J., Nurco D. N., Shaffer J. W. The veridicality of addicts' self-reports in social research. Int J Addict 1976; 11: 719-24.
38. Best J., Horiuchi G. The razor blade in the apple: the social construction of urban legends. Social Probl 1985; 32: 488-99.
39. Brunvand J. The Vanishing Hitchhiker. New York: Norton; 1981, pp. 62-9.
40. Fine D. P. The Kentucky fried rat: legends and modern society. J Folklore Inst 1980; 17: 222-43.
41. Bennett G. Legend: performance and truth. In: Bennett G., Smith P., editors. Contemporary Legend: a Reader. London and New York: Routledge; 2011, pp. 17-40.
42. Smith P. A. Legendary genre? In: Bennett G., Smith P., editors. Contemporary Legend: a Reader. London and New York: Routledge; 2011, pp. 103-12.
43. Boyes G. Belief and disbelief: an examination of reactions to the presentation of rumour legends. In: Bennett G., Smith P. editors. Contemporary Legend: a Reader. London and New York: Routledge; 2011, pp. 41-54.
44. Darke S., Ross J., Hall W. Overdose among heroin users in Sydney, Australia: I. prevalence and correlates of non-fatal overdose. Addiction 1996; 91: 405-11.
45. McGregor C., Darke S., Ali R., Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction 1998; 93: 701-11.
46. Powis B., Strang J., Griffiths P., Taylor C., Williamson S., Fountain J. et al. Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction 1999; 94: 471-8.
47. Worthington N., Piper M. T., Galea S., Rosenthal D. Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study. Harm Reduct J 2006; 3: 19.
48. Information Services Division (ISD). National Naloxone Programme Scotland-Naloxone Kits Issued in 2013/14 and Trends in Opioid-Related Deaths. Edinburgh: ISD Scotland; 2014.
49. Bird S. M., Parmar M. K., Strang J. Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland's public health policy evaluation, and a new measure to assess impact. Drugs Educ Prev Policy 2015; 22: 66-76.
50. Matheson C., Pflanz-Sinclair C., Aucott L., Wilson P., Watson R., Malloy S. et al. Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice. BMC Fam Pract 2014; 15: 12.